NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

StonkMaster,

The Sawston facility contains a total of 88,345 square feet on two floors. The initial production capacity comprises two manufacturing suites, occupying approximately 4,400 square feet (Phase 1A).These two suites are anticipated to have potential capacity to produce dendritic vaccines for up to 40 to 50 patients per month.
I anticipate that Phase 1B's construction is very similar to that of Phase 1A, suggesting that the additional suites will likely have a similar potential capacity to produce vaccines for up to 40 to 50 patients per month